Jacobs Levy Equity Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-86,949
| Closed | -$578K | – | 947 |
|
|
2024
Q2 | $578K | Sell |
86,949
-345,717
| -80% | -$2.3M | ﹤0.01% | 819 |
|
|
2024
Q1 | $4.4M | Buy |
432,666
+325
| +0.1% | +$3.31K | 0.02% | 451 |
|
|
2023
Q4 | $4.86M | Buy |
+432,341
| New | +$4.86M | 0.02% | 431 |
|
|
2017
Q2 | – | Sell |
-33
| Closed | -$8K | – | 921 |
|
|
2017
Q1 | $8K | Buy |
+33
| New | +$8K | ﹤0.01% | 909 |
|
|
2016
Q1 | – | Sell |
-172
| Closed | -$98K | – | 1099 |
|
|
2015
Q4 | $98K | Buy |
+172
| New | +$98K | ﹤0.01% | 740 |
|
|
2014
Q4 | – | Sell |
-384
| Closed | -$205K | – | 811 |
|
|
2014
Q3 | $205K | Buy |
384
+4
| +1% | +$2.14K | ﹤0.01% | 741 |
|
|
2014
Q2 | $161K | Sell |
380
-71
| -16% | -$30.1K | ﹤0.01% | 771 |
|
|
2014
Q1 | $248K | Buy |
451
+342
| +314% | +$188K | ﹤0.01% | 783 |
|
|
2013
Q4 | $61K | Sell |
109
-31
| -22% | -$17.3K | ﹤0.01% | 921 |
|
|
2013
Q3 | $88K | Sell |
140
-629
| -82% | -$395K | ﹤0.01% | 893 |
|
|
2013
Q2 | $367K | Buy |
+769
| New | +$367K | 0.01% | 786 |
|